LON: REDX 87.00GBX

Redx Virtual R&D Day with Leading Experts and New Clinical Data for ROCK2 Inhibitor Redx to host Virtual R&D Day on 11 October 2021 Redx Presents Encouraging Phase 1 Data at ESMO for its Porcupine Inhibitor RXC004 in Patients with Advanced Solid Tumours

About us
Our pipeline
Our science
- Our scientific publications
Investors
News & events
- News & events
Contact us
- Contact us
- Careers

About us
Our pipeline
Our science
- Our scientific publications
Investors
News & Events
- News & events
Contact
- Contact us
- Careers

Top suggestions

Redx Virtual R&D Day with Leading Experts and New Clinical Data for ROCK2 Inhibitor
Redx to host Virtual R&D Day on 11 October 2021
Redx Presents Encouraging Phase 1 Data at ESMO for its Porcupine Inhibitor RXC004 in Patients with Advanced Solid Tumours

Email alerts

Investor centre

Presentations, analyst reports, documents & videos

Reports & Accounts

Contact us

RSS

Copyright © 2021 Redx Pharma Plc

Privacy & terms
Cookie policy

Website design & build by Carr Kamasa Design

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. Cookie Policy.